Isgrò, G.; Rogers, A.; Veeratterapillay, R.; Rix, D.; Page, T.; Maestroni, U.; Bertolotti, L.; Pagnini, F.; Martini, C.; De Filippo, M.;
et al. Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication Rate. J. Clin. Med. 2024, 13, 31.
https://doi.org/10.3390/jcm13010031
AMA Style
Isgrò G, Rogers A, Veeratterapillay R, Rix D, Page T, Maestroni U, Bertolotti L, Pagnini F, Martini C, De Filippo M,
et al. Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication Rate. Journal of Clinical Medicine. 2024; 13(1):31.
https://doi.org/10.3390/jcm13010031
Chicago/Turabian Style
Isgrò, Gianmarco, Alistair Rogers, Rajan Veeratterapillay, David Rix, Toby Page, Umberto Maestroni, Lorenzo Bertolotti, Francesco Pagnini, Chiara Martini, Massimo De Filippo,
and et al. 2024. "Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication Rate" Journal of Clinical Medicine 13, no. 1: 31.
https://doi.org/10.3390/jcm13010031
APA Style
Isgrò, G., Rogers, A., Veeratterapillay, R., Rix, D., Page, T., Maestroni, U., Bertolotti, L., Pagnini, F., Martini, C., De Filippo, M., & Ziglioli, F.
(2024). Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication Rate. Journal of Clinical Medicine, 13(1), 31.
https://doi.org/10.3390/jcm13010031
